Cargando…
Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
Stroke is an important cause of disability and death worldwide, with the majority of strokes occurring in older people. Thrombolysis with recombinant tissue plasminogen activator (r-TPA) is the approved treatment for acute ischemic stroke. A major concern of physicians, who treat acute ischemic stro...
Autores principales: | Mehrpour, Masoud, Motamed, Mohammad Reza, Aghaei, Mahboubeh, Badi, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829293/ https://www.ncbi.nlm.nih.gov/pubmed/24250917 |
Ejemplares similares
-
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013) -
Unusual Recovery of Aphasia in a Polyglot Iranian Patient after Ischemic Stroke
por: Mehrpour, Masoud, et al.
Publicado: (2014) -
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023) -
Intravenous Thrombolysis for Acute Ischemic Stroke Due to Cardiac Myxoma
por: Esmaeili, Sara, et al.
Publicado: (2020) -
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative
por: Sasanejad, Payam, et al.
Publicado: (2021)